OMCL Omnicell, Inc.
Healthcare$44.37+0.00%OpenMarket Cap: $2.02B
As of 2026-05-26
Valuation
P/E (TTM)
763.91
PEG
—
P/B
1.60
P/S
1.65
EV/EBITDA
16.36
DCF Value
$24.20
FCF Yield
5.5%
Div Yield
0.0%
Margins & Returns
Gross Margin
43.5%
Operating Margin
2.8%
Net Margin
1.7%
ROE
1.6%
ROA
1.0%
ROIC
1.2%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $309.9M | 45.3% | $16.9M | $11.4M | $— | — |
| Q4 null | $314.0M | 41.5% | $1.4M | $-2.0M | $— | — |
| FY null | $1.18B | 42.9% | $11.7M | $2.1M | $— | — |
| Q3 null | $310.6M | 43.3% | $8.2M | $5.5M | $— | — |
| Q2 null | $290.6M | 43.9% | $8.1M | $5.6M | $— | — |
| Q1 null | $269.7M | 41.1% | $-11.6M | $-7.0M | $— | — |
| Q4 null | $306.9M | 46.6% | $13.8M | $15.8M | $— | — |
| FY null | $1.11B | 42.3% | $337.0K | $12.5M | $— | — |
| Q3 null | $282.4M | 43.5% | $7.2M | $8.6M | $— | — |
| Q2 null | $276.8M | 41.3% | $3.2M | $3.7M | $— | — |
| Q1 null | $246.2M | 38.7% | $-18.7M | $-15.7M | $— | — |
| Q4 2023 | $258.8M | 40.7% | $-23.4M | $-14.4M | $-0.32 | — |